Target Audience:
This initiative is intended for cardiologists, primary care physicians (PCPs), nurses, nurse practitioners (NPs), and physician assistants (PAs) involved in the care of patients with or at risk for CVD cardiovascular disease (CVD) or cardiometabolic diseases.
Learning Objectives:
Upon completion of this conference, learners will have
- Increased knowledge regarding the:
- Latest clinical practice guidelines for the care of patients across the spectrum of cardiovascular (CV)/cardiometabolic conditions
- Clinical trial data on new and emerging therapies across the spectrum of CVD/cardiometabolic disease
- Greater confidence in their ability to recognize the distinct and complimentary roles of the interdisciplinary team in the coordinated management of CV and cardiometabolic disease to improve communication, care integration, and patient outcomes.
- Greater competence related to tailoring treatments for patients with CVD, cardiometabolic disease, and/or comorbidities
Joint Accreditation Statement
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 12.75 contact hour(s) of nursing continuing professional development for RNs and APNs; final contact hours in the area of pharmacology will be posted on the conference platform.
This activity was planned by and for the healthcare team, and learners will receive 12.75 Interprofessional Continuing Education (IPCE) credit for learning and change.
